The trial will assess if direct outreach by healthcare providers increases cascade genetic testing among first-degree ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, ...

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...

GREENSBORO, N.C. (WGHP) — A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart disease, and it’s completely free. “Some people do ...

People who skip colorectal cancer screening because colonoscopy or stool testing seems too burdensome now have a blood test ...

It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger ...

The diagnosis of Lynch syndrome in patients with colorectal cancer has evolved from reliance on clinical criteria to integrated molecular and genetic approaches. Genetic testing strategies typically ...